Published December 11, 2020
For all the latest news and updates, consult UB's COVID-19 site.
The saliva test used in UB’s COVID-19 surveillance testing was named by the Food and Drug Administration the best of its kind for detecting the virus in its earliest stages. The test, developed by Upstate Medical University and Quadrant Biosciences, was also cited as being among the most sensitive tests regardless of type, ranking 6th worldwide in detecting the virus. UB launched its surveillance testing program in September to monitor the prevalence of the virus among the university community. More than 31,000 tests have been conducted, yielding a very low positivity rate of less than 1%.
UB’s COVID-19 planning and response site provided timely, accurate information to the UB community during the fall semester, garnering more than 300,000 views. When the plan for the 2021 spring semester is finalized and approved by SUNY, which is expected to take place soon, the site will be updated with new information.